Retraction and republication—Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment (The Lancet Diabetes & Endocrinology (2018) 6(6) (e6–e15) (S2213858718301505) (10.1016/S2213-8587(18)30150-5));Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment

The Lancet Diabetes and Endocrinology

Volumn 6, Issue 6, 2018, Pages e6-e15

  Pearson Stuttard, Jonathan ^a   Zhou, Bin ^a   Kontis, Vasilis ^a   Bentham, James ^a,b   Gunter, Marc J ^c   Ezzati, Majid ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE BURDEN; DISEASE COURSE; ENDOMETRIUM CANCER; FEMALE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX;

EID: 85046562086     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(18)30146-3     Document Type: Erratum

References (50)

1. Lim, SS, Vos, T, Flaxman, AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2224–2260.
2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet, 2017 published online Oct 10. http://dx.doi.org/10.1016/S0140-6736(17)32129-3.
3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 387 (2016), 1513–1530.
4. World Cancer Research Fund, American Institute for Cancer Research Food. Continuous update project. Colorectal cancer 2011 report. Nutrition, physical activity, and the prevention of colorectal cancer. 2011, World Cancer Research Fund, London.
5. World Cancer Research Fund, American Institute for Cancer Research. Continuous update project. Diet, nutrition, physical activity and gallbladder cancer. 2015, World Cancer Research, London.
6. World Cancer Research Fund, American Institute for Cancer Research. Continuous update project. Pancreatic cancer 2012 report. Food, nutrition, physical activity, and the prevention of pancreatic cancer. 2012, World Cancer Research Fund, London.
7. World Cancer Research Fund, American Institute for Cancer Research. Continuous update project. Diet, nutrition, physical activity, and kidney cancer. 2015, World Cancer Research Fund, London.
8. World Cancer Research Fund, American Institute for Cancer Research. Continuous update project. Diet, nutrition, physical activity, and liver cancer. 2015, World Cancer Research Fund, London.
9. World Cancer Research Fund, American Institute for Cancer Research. Continuous update project. Endometrial cancer 2013 report. Food, nutrition, physical activity, and the prevention of endometrial cancer. 2013, World Cancer Research Fund, London.
10. World Cancer Research Fund, American Institute for Cancer Research. Continuous update project. Breast cancer 2010 report. Food, nutrition, physical activity, and the prevention of breast cancer. 2010, World Cancer Research Fund, London.
11. World Cancer Research Fund, American Institute for Cancer Research. Continuous update project. Ovarian cancer 2014 report. Food, nutrition, physical activity, and the prevention of ovarian cancer. 2014, World Cancer Research Fund, London.
12. World Cancer Research Fund, American Institute for Cancer Research. Continuous update project. Diet, nutrition, physical activity, and stomach cancer. 2016, World Cancer Research Fund, London.
13. Lauby-Secretan, B, Scoccianti, C, Loomis, D, Grosse, Y, Bianchini, F, Straif, K, Body fatness and cancer—viewpoint of the IARC Working Group. N Engl J Med 375 (2016), 794–798.
14. World Cancer Research Fund, American Institute for Cancer Research. Continuous update project. Diet, nutrition, physical activity, and oesophageal cancer. 2016, World Cancer Research Fund, London.
15. Arnold, M, Pandeya, N, Byrnes, G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol 16 (2015), 36–46.
16. Kyrgiou, M, Kalliala, I, Markozannes, G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ, 356, 2017, j477.
17. Tsilidis, KK, Kasimis, JC, Lopez, DS, Ntzani, EE, Ioannidis, JPA, Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ, 350, 2015, g7607.
18. Ferlay, J, Soerjomataram, I, Ervik, M, et al. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 v1.0. IARC CancerBase no. 11. 2013, International Agency for Research on Cancer, Lyon.
19. Elliott, AM, Aucott, LS, Hannaford, PC, Smith, WC, Weight change in adult life and health outcomes. Obes Res 13 (2005), 1784–1792.
20. Ezzati, M, Lopez, AD, Rodgers, A, Vander Hoorn, S, Murray, CJL, Selected major risk factors and global and regional burden of disease. Lancet 360 (2002), 1347–1360.
21. Murray, CJ, Ezzati, M, Lopez, AD, Rodgers, A, Vander Hoorn, S, Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr, 1, 2003, 1.
22. Hwang, CK, Han, PV, Zabetian, A, Ali, MK, Venkat Narayan, KM, Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis. Diabetes Res Clin Pract 96 (2012), 271–285.
23. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 387 (2016), 1377–1396.
24. Ezzati, M, Hoorn, SV, Rodgers, A, Lopez, AD, Mathers, CD, Murray, CJ, Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 362 (2003), 271–280.
25. R Development Core Team. R: a language and environment for statistical computing. 2014, R Foundation for Statistical Computing, Vienna.
26. Danaei, G, Vander Hoorn, S, Lopez, AD, Murray, CJL, Ezzati, M, Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366 (2005), 1784–1793.
27. Ezzati, M, Henley, S, Lopez, A, Thun, M, Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer 116 (2005), 963–971.
28. Plummer, M, de Martel, C, Vignat, J, Ferlay, J, Bray, F, Franceschi, S, Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 4 (2016), e609–e616.
29. Giovannucci, E, Harlan, DM, Archer, MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 33 (2010), 1674–1685.
30. Nead, KT, Sharp, SJ, Thompson, DJ, et al. Evidence of a causal association between insulinemia and endometrial cancer: a Mendelian randomization analysis. J Natl Cancer Inst, 107, 2015, djv178.
31. Murphy, N, Cross, AJ, Abubakar, M, et al. A nested case–control study of metabolically defined body size phenotypes and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS Med, 13, 2016, e1001988.
32. Liang, X, Margolis, KL, Hendryx, M, et al. Metabolic phenotype and risk of colorectal cancer in normal-weight postmenopausal women. Cancer Epidemiol Biomarkers Prev 26 (2017), 155–161.
33. Gunter, MJ, Xie, X, Xue, X, et al. Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Res 75 (2015), 270–274.
34. De Bruijn KMJ, Ruiter R, de Keyser CE, Hofman A, Stricker BH, van Eijck CHJ. Detection bias may be the main cause of increased cancer incidence among diabetics: results from the Rotterdam Study. Eur J Cancer; 50: 2449–55.
35. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004), 157–163.
36. Singh, GM, Danaei, G, Farzadfar, F, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One, 8, 2013, e65174.
37. Jee, SH, Sull, JW, Park, J, et al. Body-mass index and mortality in Korean men and women. N Engl J Med 355 (2006), 779–787.
38. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373 (2009), 1083–1096.
39. Asia Pacific Cohort Studies Collaboration. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol 33 (2004), 751–758.
40. Lu, Y, Hajifathalian, K, Ezzati, M, Woodward, M, Rimm, EB, Danaei, G, Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet 383 (2014), 970–983.
41. Abdullah, A, Wolfe, R, Stoelwinder, JU, et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol 40 (2011), 985–996.
42. The Global Burden of Metabolic Risk Factors for deases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2 (2014), 634–647.
43. Hales, C, Barker, D, Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Int J Epidemiol 42 (2013), 1215–1222.
44. Chambers, JC, Zhang, W, Zabaneh, D, et al. Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes 58 (2009), 2703–2708.
45. Ramachandran, A, Wan Ma, RC, Snehalatha, C, Diabetes in Asia. Lancet 375 (2010), 408–418.
46. Bhargava, SK, Sachdev, HS, Fall, CHD, et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 350 (2004), 865–875.
47. Chan, J, Malik, VS, Jia, W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301 (2009), 2129–2140.
48. Knowler, WC, Barrett-Connor, E, Fowler, SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
49. Ley, SH, Hamdy, O, Mohan, V, Hu, FB, Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 383 (2014), 1999–2007.
50. Holman, RR, Paul, SK, Bethel, MA, Matthews, DR, Neil, HAW, 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008), 1577–1589.